Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Authors
Keywords
Clinical trial, Japanese, Long term, Parkinson’s disease, Rasagiline
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 126, Issue 3, Pages 299-308
Publisher
Springer Nature
Online
2019-01-29
DOI
10.1007/s00702-018-1964-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and Safety of Single and Multiple Doses of Rasagiline in Healthy Japanese and Caucasian Subjects
- (2018) Anna Elgart et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan
- (2018) Nobutaka Hattori et al. PARKINSONISM & RELATED DISORDERS
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Long-term effects of rasagiline and the natural history of treated Parkinson's disease
- (2016) Olivier Rascol et al. MOVEMENT DISORDERS
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- Time Trends in the Incidence of Parkinson Disease
- (2016) Rodolfo Savica et al. JAMA Neurology
- Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
- (2016) John P. M. Finberg et al. Frontiers in Pharmacology
- Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
- (2015) Daphne Robakis et al. CNS DRUGS
- Minimal clinically important difference on the Motor Examination part of MDS-UPDRS
- (2015) Krisztina Horváth et al. PARKINSONISM & RELATED DISORDERS
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- How should we treat a patient with early Parkinson’s disease?
- (2010) S. Tsouli et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Long-Term Efficacy of Rasagiline in Early Parkinson's Disease
- (2010) Mark F. Lew et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now